Fatal combined immune hemolytic anemia after double cord blood transplantation in imatinib-resistant CML

Saved in:

Bibliographic Details
Published in:	Bone marrow transplantation (Basingstoke) Vol. 44; no. 6; pp. 383 - 385
Main Authors:	Rokicka, M, Styczynski, J, Michalewska, B, Torosian, T, Tomaszewska, A, Gronkowska, A, Pogorzala, M, Wysocki, M, Lakomy, M, Wiktor-Jedrzejczak, W
Format:	Journal Article
Language:	English
Published:	London Nature Publishing Group UK 01-09-2009 Nature Publishing Group
Subjects:	Anemia Anemia, Hemolytic - complications Anemia, Hemolytic - immunology Anemia, Hemolytic, Autoimmune - etiology Antibodies, Anti-Idiotypic - blood Antineoplastic Agents - therapeutic use Benzamides Care and treatment Case studies Cell Biology Chronic myeloid leukemia Complications and side effects Cord blood Cord Blood Stem Cell Transplantation - adverse effects Cyclosporine - therapeutic use Development and progression Drug Resistance, Neoplasm Fatal Outcome Female Fetal blood Graft vs Host Disease - prevention & control Hematology Hemolytic anemia Humans Imatinib Imatinib Mesylate Immune hemolytic anemia Immunosuppressive Agents - therapeutic use Internal Medicine letter-to-the-editor Leukemia, Myeloid, Chronic-Phase - complications Leukemia, Myeloid, Chronic-Phase - therapy Medicine Medicine & Public Health Piperazines - therapeutic use Public Health Pyrimidines - therapeutic use Splenectomy Stem cell transplantation Stem Cells Transfusion Reaction Transplantation Transplantation Conditioning Young Adult
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Bibliography:	ObjectType-Case Study-2 SourceType-Scholarly Journals-1 ObjectType-Correspondence-3 content type line 23 ObjectType-Report-1
ISSN:	0268-3369 1476-5365 1476-5365
DOI:	10.1038/bmt.2009.25